TCW funds, an investment management company, released its “TCW Relative Value Mid Cap Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.

Amcor, Aptar Group, CCL Industries, Gerresheimer AG, Schott AG, SGD Pharma, West Pharmaceutical Services — are examined.

Bright Path, a U.S.-based advanced pharmaceutical manufacturer, today welcomed President Trump's proclamation imposing tariffs of up to 100 percent on imported patented pharmaceuticals and active ...

This guide explores how capsule counting machines work, why they matter, and what to consider when choosing one for your ...

Britain has finalised a U.S.-UK pharmaceutical trade deal, setting out tariff-free ​access for UK-made medicines to the U.S.

Overcoming common challenges with today’s biologics, such as developing devices for high-concentration subcutaneous ...

Learn how pharma company Pfizer makes money through prescription drugs, vaccines, oncology treatments, and global ...

Explore how life-science companies adapt office spaces to balance hybrid work flexibility with the need for innovation, ...

In the first instance, Bindbridge is looking to develop a new broad spectrum non specific herbicide that can replace ...

CCL Healthcare reports that smart packaging in healthcare enhances compliance and safety through technologies like RFID, NFC, and TTIs, amid rising counterfeiting risks.

BullFrog AI (BFRG) stock jumped 106% after announcing a drug discovery deal with a top-5 pharma firm targeting major ...

Over one billion people worldwide are over 60, and the population is projected to more than double by 2050. But as more ...